Replies to post #2799 on BioAdaptives Inc (BDPT)

[Max2121]

Great DD’s.

[powerbattles]

$BDPT has all the ingredients of a monster runner...

This company stands out as one of the most solid and fundamentally strong investments I've come across in my years of researching of companies on the OTC market. It's a true gem worth considering.

$BDPT PENDING A GLOBAL DRUG SPIN-OFF:))) Massive upside coming...

DD part # 1 Good times ahead! SPIN-OFF
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172123754

Folks aren’t buying for what the company currently has…they’re buying for the massive potential of this #biotech stock after all the news/PR’s in March & April. New BOD’s & licensing to NEW products w/patents valued at over $750 million…the spin-off is coming; also ties to #AI

It appears that the company is poised for the next phase of growth. The recent high-profile recruitments at BioAdaptives since April 2023 have been incredibly exciting for the company. These recruitments include top-notch professionals who are prepared to take us to the next level, potentially even securing a listing on a larger exchange.

CEO Graduated the best Ivy League school Leagues. Graduate of Harvard Medical school and Princeton University. IVY Legue School ranked
1 - HARVARD
2 - PRINCETON
https://prepexpert.com/ivy-league-school-rankings/#:~:text=Ivy%20League%20Schools%3A%20Ranked%201%201.%20Harvard%20Harvard,7%207.%20Dartmouth%20...%208%208.%20Cornell%20

Recent announcements of new board members, an upcoming spin-off, new products/patents/licensing agreements, and more.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172165338

FOUR REASONS WHY WE CAN ASSURE DILUTE IS OVER.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172260092